PACTR201906616852062招募中未知
A comprehensive intervention for cardiovascular disease prevention in selected primary health care facilities in Capricorn District, South Africa: An effectiveness-implementation study
niversity of Limpopo0 个研究点目标入组 600 人开始时间: 2019年4月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •1. Both male and female
- •2. Aged 18 years and above
- •3. Consent to participate in the study
排除标准
- •1. Below age of 18
- •2. Those not consenting to participate
- •3. Those not falling withing the catchment areas of the identified 11 clinics in Capricorn District, Limpopo Province, South Africa.
研究者
相似试验
进行中（未招募）
1 期
ew treatments to reduce cardiovascular disease in type 1 diabetesType 1 diabetesCTIS2023-505794-32-04Steno Diabetes Center Copenhagen2,000
进行中（未招募）
Unknown
MiFoot – reducing heart disease risk in those with a history of diabetic foot ulcersNutritional, Metabolic, EndocrineDiabetesISRCTN13413505niversity of Leicester392
进行中（未招募）
不适用
Comparison between 2 different hydration strategies (saline solution vs carbonati) for the prevention of contrast induced nephropaty in patients at risk for heart failure undergoing coronary angiography or interventioPatients undergoing coronary angiography or angioplastyMedDRA version: 14.1Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersEUCTR2011-003611-37-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA' DI NOVARA240
进行中（未招募）
不适用
PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecrosiS in elective coronary angioplasty. A prospective double-blind randomized trial (PREVENT ICARUS) trial - PREVENT-ICARUSElective coronary angioplastyMedDRA version: 9.1Level: SOCClassification code 10047065EUCTR2009-013681-92-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
进行中（未招募）
1 期
Treatment of heart and blood vessel disease (cardiovascular disease) with low dose blood thinner (low dose rivaroxaban) in people with advanced kidney disease or receiving dialysis (advanced chronic kidney disease).Improvement of cardiovascular outcomes in patients with advancedchronic kidney disease. In easily understood language, this is Heart and blood vessel disease and Kidney disease.CTIS2024-512483-59-00The George Institute For Global Health2,000